Psoriasis: Obesity and Fatty Acids
Psoriasis is chronic inflammatory skin disease affecting skin, joints, cardiovascular system, brain, and metabolism. The pathogenesis of psoriasis is mediated by a complex interplay between the immune system, inflammatory mediators of different pathways, e.g., TNF-alpha and the IL-23/IL-17 pathways,...
Main Authors: | Manfred Kunz, Jan C. Simon, Anja Saalbach |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-07-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fimmu.2019.01807/full |
Similar Items
-
The impact of obesity on psoriasis
by: Dorota Krasowska, et al.
Published: (2016-09-01) -
Biologic Treatment in Combination with Lifestyle Intervention in Moderate to Severe Plaque Psoriasis and Concomitant Metabolic Syndrome: Rationale and Methodology of the METABOLyx Randomized Controlled Clinical Trial
by: Andreas Pinter, et al.
Published: (2021-08-01) -
Abnormal serum fatty acid profile in psoriatic arthritis
by: Hanna Mysliwiec, et al.
Published: (2019-11-01) -
Reduced Serum Levels of Bone Formation Marker P1NP in Psoriasis
by: Julia Mentzel, et al.
Published: (2021-10-01) -
Impact of Maternal Obesity on the Metabolism and Bioavailability of Polyunsaturated Fatty Acids during Pregnancy and Breastfeeding
by: Daniela Álvarez, et al.
Published: (2021-12-01)